| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.66B | +74.0% |
| Cost of Revenue | $997.5M | +239.3% |
| Gross Profit | $657.6M | +0.0% |
| R&D Expense | $123.8M | +16.3% |
| SG&A Expense | $73.1M | -25.1% |
| Operating Income | $108.5M | -26.8% |
| Pre-tax Income | $111.4M | -25.4% |
| Income Tax | $32.4M | -16.9% |
| Net Income | $84.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $469.5M | +102.4% |
| Accounts Receivable | $46.8M | -75.3% |
| Inventory | $5.3M | -73.1% |
| Current Assets | $557.4M | -1.0% |
| Total Assets | $927.1M | -0.5% |
| Current Liabilities | $98.7M | -42.2% |
| Long-term Debt | $0 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $256.1M | +160.6% |
| Capital Expenditures | $5.9M | -23.2% |
| Investing Cash Flow | $72.7M | +206.7% |
| Financing Cash Flow | -$92.6M | -620.1% |
| Free Cash Flow | $250.2M | +176.2% |
| -22.8% |
| EPS (Basic) | $1.64 | — |
| EPS (Diluted) | $0.62 | — |
| Total Liabilities |
| $155.7M |
| -38.2% |
| Stockholders' Equity | $734.6M | +42.1% |